ArticleAnnals of translational medicine2022

Apatinib plus 5-fluorouracil as a third or subsequent-line treatment option for metastatic colorectal cancer: a phase-II, single-arm, prospective study.

Runzhi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.